RAD52 could predict overall survival for patients with renal clear cell carcinoma

RAD52 could predict overall survival for patients with renal clear cell carcinoma

Bibliographic Details
Main Authors:	Mei Chen, Yuhan Xiao, Liying Zhang
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Asian Journal of Surgery
Subjects:	RAD52 KIRC Overall survival Tumor immune microenvironment
Online Access:	http://www.sciencedirect.com/science/article/pii/S101595842300502X

Similar Items

SUZ12P1 could serve as a prognostic biomarker for patients with renal clear cell carcinoma
by: Mei Chen, et al.
Published: (2023-09-01)

Construction and validation of a prognostic model for kidney renal clear cell carcinoma based on podocyte‐associated genes
by: Can Chen, et al.
Published: (2022-10-01)

Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma
by: Zhiyong Cai, et al.
Published: (2022-09-01)

Rad52-Rad51 association is essential to protect Rad51 filaments against Srs2, but facultative for filament formation
by: Emilie Ma, et al.
Published: (2018-07-01)

Deletion of RAD52 in Saccharomyces cerevisiae severely decreases frequencies of Agrobacterium genetic transformation mediated by either an integrative or a replicating binary vector
by: Jalal Soltani, et al.
Published: (2012-06-01)

Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma
by: Zhong-Hao Ji, et al.
Published: (2022-07-01)

Rad52 Oligomeric N-Terminal Domain Stabilizes Rad51 Nucleoprotein Filaments and Contributes to Their Protection against Srs2
by: Emilie Ma, et al.
Published: (2021-06-01)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
by: Ping Li, et al.
Published: (2019-11-01)

The signature genes of cuproptosis associates with tumor immune microenvironment and predicts prognosis in kidney renal clear cell carcinoma
by: Shuhan Liu, et al.
Published: (2024-08-01)

A novel specific ferroptosis marker PRDX3: A hero or a villain in clear-cell renal cell carcinoma?
by: Hongquan Liu, et al.
Published: (2024-04-01)

Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinoma
by: Qingshui Wang, et al.
Published: (2024-05-01)

A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma
by: Qianwei Xing, et al.
Published: (2021-04-01)

Research on molecular characteristics of ADME-related genes in kidney renal clear cell carcinoma
by: Haiyu Zhang, et al.
Published: (2024-07-01)

The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations
by: Aaron W. Adamson, et al.
Published: (2020-06-01)

Bioinformatics-driven identification of prognostic biomarkers in kidney renal clear cell carcinoma
by: Varinder Madhav Verma, et al.
Published: (2024-04-01)

Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma
by: Xiao-Liang Xing, et al.
Published: (2022-05-01)

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
by: Xiaochen Qi, et al.
Published: (2022-06-01)

The role and therapeutic significance of the anoikis pathway in renal clear cell carcinoma
by: Jin Wang, et al.
Published: (2022-09-01)

Toll-Like Receptors Serve as Biomarkers for Early Diagnosis and Prognosis Assessment of Kidney Renal Clear Cell Carcinoma by Influencing the Immune Microenvironment: Comprehensive Bioinformatics Analysis Combined With Experimental Validation
by: Xiong Zou, et al.
Published: (2022-01-01)

Development and validation of a novel immunotype for prediction of overall survival in patients with clear cell renal cell carcinoma
by: Deshui Yu, et al.
Published: (2022-09-01)

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma
by: Qian Chen, et al.
Published: (2020-10-01)

Small-molecule inhibitors identify the RAD52-ssDNA interaction as critical for recovery from replication stress and for survival of BRCA2 deficient cells
by: Sarah R Hengel, et al.
Published: (2016-07-01)

Prognostic nomogram that predicts progression-free survival and overall survival of patients with ovarian clear cell carcinoma
by: Jiayi Li, et al.
Published: (2022-10-01)

Identification and validation of shared gene signature of kidney renal clear cell carcinoma and COVID-19
by: Jianqiang Nie, et al.
Published: (2024-03-01)

Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
by: Xinyi Zeng, et al.
Published: (2024-08-01)

Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma
by: Zhijun Han, et al.
Published: (2022-08-01)

PTK6: An emerging biomarker for prognosis and immunotherapeutic response in clear cell renal carcinoma (KIRC)
by: Lizhen Lin, et al.
Published: (2024-04-01)

TGF-β superfamily-induced transcriptional activation pathways establish the RAD52-dependent ALT machinery during malignant transformation of MPNSTs
by: Eunji Choi, et al.
Published: (2024-11-01)

ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma
by: Haofei Wang, et al.
Published: (2017-03-01)

TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma
by: Hongbo Wang, et al.
Published: (2023-11-01)

Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma
by: Dongliang Yang, et al.
Published: (2023-12-01)

Yeast Srs2 Helicase Promotes Redistribution of Single-Stranded DNA-Bound RPA and Rad52 in Homologous Recombination Regulation
by: Luisina De Tullio, et al.
Published: (2017-10-01)

Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma
by: Yuzhi Jin, et al.
Published: (2024-02-01)

Exploring the crosstalk of immune cells: The impact of dysregulated RUNX family genes in kidney renal clear cell carcinoma
by: Zhiwei Jiang, et al.
Published: (2024-05-01)

Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma
by: Qi-Dong Xia, et al.
Published: (2023-03-01)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
by: Yue Zhang, et al.
Published: (2022-12-01)

Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
by: Jiahao Xu, et al.
Published: (2022-12-01)

Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma
by: Yonghao Sun, et al.
Published: (2022-06-01)

Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma
by: Yuanyuan Feng, et al.
Published: (2024-03-01)

The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients
by: Zicheng Wang, et al.
Published: (2022-07-01)